Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Groh

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Rheumatology (Oxford, England)|May 24, 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation studyBoris Sorin, Matthias Papo, Renato Alberto Sinico, et al.
The British Journal of Dermatology|July 21, 2022
Cutaneous manifestations of lymphoid-variant hypereosinophilic syndromeClaire Laurent, Guillaume Lefèvre, Jean-Emmanuel Kahn, et al.
Journal of Autoimmunity|November 16, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factorsBoris Sorin, Matthias Papo, Renato A Sinico, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2026
Prognosis and long term outcome of stenotic large vessel involvement in giant cell arteritisGeorgina Maalouf, Bérangère Arnould, Olivier Espitia, et al.
The Journal of Rheumatology|December 3, 2019
Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody-associated Vasculitis-related Bronchiectasis: Data from 61 PatientsRaphael Lhote, Marie Chilles, Matthieu Groh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 1, 2020
Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative StudyAlice Canzian, Nils Venhoff, Maria Letizia Urban, et al.
American Journal of Hematology|July 29, 2020
Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: Data from 151 patientsJulien Rohmer, Amélie Couteau-Chardon, Julie Trichereau, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 2, 2024
Clinical picture, outcomes, and predictors of relapse in eosinophilia-associated coronary vasospasm: Data from a European multicentric studyFlorent Huang, Lucas Rémi Khellaf, Guillaume Lefèvre, et al.
American Journal of Hematology|April 2, 2024
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO studyMatthieu Groh, Laurène Fenwarth, Mathilde Labro, et al.
Journal of the American Academy of Dermatology|November 14, 2020
Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): A multicenter retrospective study of 119 patientsElina Zuelgaray, Sylvie Chevret, Marie Jachiet, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Rheumatology (Oxford, England)|May 24, 2025
Glucocorticoids vs glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors: a target trial emulation studyBoris Sorin, Matthias Papo, Renato Alberto Sinico, et al.
The British Journal of Dermatology|July 21, 2022
Cutaneous manifestations of lymphoid-variant hypereosinophilic syndromeClaire Laurent, Guillaume Lefèvre, Jean-Emmanuel Kahn, et al.
Journal of Autoimmunity|November 16, 2024
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factorsBoris Sorin, Matthias Papo, Renato A Sinico, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2026
Prognosis and long term outcome of stenotic large vessel involvement in giant cell arteritisGeorgina Maalouf, Bérangère Arnould, Olivier Espitia, et al.
The Journal of Rheumatology|December 3, 2019
Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody-associated Vasculitis-related Bronchiectasis: Data from 61 PatientsRaphael Lhote, Marie Chilles, Matthieu Groh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 1, 2020
Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative StudyAlice Canzian, Nils Venhoff, Maria Letizia Urban, et al.
American Journal of Hematology|July 29, 2020
Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: Data from 151 patientsJulien Rohmer, Amélie Couteau-Chardon, Julie Trichereau, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 2, 2024
Clinical picture, outcomes, and predictors of relapse in eosinophilia-associated coronary vasospasm: Data from a European multicentric studyFlorent Huang, Lucas Rémi Khellaf, Guillaume Lefèvre, et al.
American Journal of Hematology|April 2, 2024
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO studyMatthieu Groh, Laurène Fenwarth, Mathilde Labro, et al.
Journal of the American Academy of Dermatology|November 14, 2020
Trunk involvement and peau d'orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): A multicenter retrospective study of 119 patientsElina Zuelgaray, Sylvie Chevret, Marie Jachiet, et al.
Pageof 12